Global Osteoporosis Therapeutics Market to Reach US$11.1 Billion by 2010, According to New Report by Global Industry Analysts
Worldwide osteoporosis therapeutics market is projected to reach US$11.1 billion in sales by 2010. Aging population, continuing new product introductions, growing awareness of osteoporosis, and expansion of bone densitometry scanning are the prime growth drivers in the worldwide osteoporosis therapeutics market. However with the launch of newer treatments coupled with the patent expiry of major drugs including Fosamax, Actonel, and Boniva, growth in the market for osteoporosis therapeutics is expected to slow down by 2015. (PRWeb Feb 26, 2008)
Read the full story at [Please register to see this link Register]
[Please register to see this link
Register]